Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Arrowhead Pharmaceuticals Inc. logo

Arrowhead Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Biotechnology

30.20
 
USD
  
1.02
  
(3.50%)
Optionable: Yes  Market Cap: 3,620 M  90-day average vol: 1,628,491

Previous close: 29.18  Open: 29.27  Bid: 30.0  Ask: 30.9
52 week range    
20.67   
   42.48
Peers   
ALNY / 
LGND / 
JNJ / 
INO / 
NANX / 
Last updated: Friday 23rd February 2024
33
MarketXLS Rank
40
Value
23
Technical
36
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ALNY

17 B-19.3148.65

INO

1 B-3.93.8

JNJ

0.0247450 B22.1171.06

LGND

2 B31.2124.04

MRNA

70 B10.4160.27

NANX

0 B41.63.73
Financials

ARWR Income Statement

Annual
Sep-14Sep-15Sep-16Sep-17Sep-18Sep-19Sep-20Sep-21Sep-22Sep-23
Amortization of intangibles-54653.0-1 M-2 M-2 M-2 M2 M2 M2 M2 M2 M
Basic EPS from continuing operations-1.25-1.6-1.340.72-0.84-1.36-1.67-1.92
Basic EPS total-1.25-1.6-1.34-0.650.72-0.84-1.36-1.67-1.92
Basic weighted shares outstanding47 M57 M61 M74 M84 M94 M101 M104 M105 M107 M
Depreciation1 M2 M3 M-3 M-3 M3 M4 M7 M9 M11 M
Depreciation unreconciled1 M2 M3 M5 M
DepreciationAndAmortization1 M2 M3 M-3 M-3 M3 M4 M7 M9 M11 M
DevelopmentExpense20 M
Diluted EPS total-1.25-1.6-1.34-0.47-0.650.69-0.84-1.36-1.67-1.92
Diluted normalized net income/share0.69-0.84-1.36-1.67-1.92
Diluted weighted shares outstanding47 M57 M61 M73 M84 M99 M101 M104 M105 M107 M
Earnings from equity interest-78874.0
EarningsFromEquityInterestNetOfTax-78874.0
ExciseTaxes6 M12 M
GainOnSaleOfPPE-58878.019195.0
GainOnSaleOfSecurity-6 M3 M-301022.0890362.0432141.0
GeneralAndAdministrativeExpense6 M8 M10 M17 M19 M27 M52 M81 M124 M93 M
Gross operating profit-6 M382000.0158333.031 M16 M169 M88 M138 M243 M241 M
ImpairmentOfCapitalAssets2 M
Income before tax-59 M-92 M-70 M-34 M-54 M68 M-85 M-141 M-173 M-206 M
Income restructuring and M&A-90 M-279 M
Income taxes5300.02400.02400.02400.02400.0173553.02000.02000.04 M3 M
Interest income645493.0729158.0265794.0415128.01 M7 M9 M6 M5 M
InterestExpenseNonOperating-645493.018 M
MinorityInterests95222.0244 M462 M409 M431000.04 M
MiscOtherSpecialCharges82092.0417874.057352.01 M7493.022 M-583000.02 M6 M17 M
Net income from total operations-59 M-92 M-82 M-34 M-54 M68 M-85 M-141 M-176 M-205 M
NetIncomeCommonStockholders-59 M-92 M-82 M-34 M-54 M68 M-85 M-141 M-176 M-205 M
NetIncomeContinuousOperations-59 M-92 M-82 M-34 M-54 M68 M-85 M-141 M-176 M-205 M
NetNonOperatingInterestIncomeExpense645493.0729158.0265794.0415128.01 M7 M9 M6 M5 M-18 M
Normalized income-163 M
Operating income-49 M-94 M-74 M-37 M-56 M61 M-93 M-149 M-179 M-205 M
Operating income before depreciation (EBITDA)-57 M-88 M-67 M-30 M-50 M73 M-79 M-133 M-162 M-176 M
OperatingExpense43 M94 M74 M-68 M-72 M108 M181 M287 M422 M446 M
Other income net11 M-1 M-6 M-2 M-439634.0-22 M583000.0-2 M-6 M-17 M
OtherGandA6 M8 M10 M17 M19 M27 M52 M81 M124 M93 M
OtherImpairmentOfCapitalAssets2 M-944935.0
OtherOperatingExpenses10 M10 M-3 M
RentAndLandingFees17 M19 M2 M
Research & development expense23 M68 M41 M51 M53 M81 M129 M206 M297 M353 M
ResearchExpense23 M47 M41 M51 M53 M81 M129 M206 M297 M353 M
RestructringAndMnAIncome-90 M-279 M
Revenue per share-54653.0-1 M-2 M-2 M-2 M2 M2 M2 M2 M2 M
SalariesAndWages13 M17 M19 M25 M
Selling Gen & administrative expense6 M8 M10 M17 M19 M27 M52 M81 M124 M93 M
Special income/charges-2 M90 M279 M
Total Income available for interest expense (EBIT)-59 M-92 M-70 M-34 M-54 M68 M-85 M-141 M-173 M-188 M
Total common shares outstanding55 M60 M74 M75 M92 M96 M103 M105 M106 M107 M
Total net income-59 M-92 M-82 M-34 M-54 M68 M-85 M-141 M-176 M-205 M
Total ordinary shares124 M124 M124 M124 M124 M124 M124 M124 M124 M124 M
Total revenues175000.0382000.0158333.031 M16 M169 M88 M138 M243 M241 M
TotalExpenses43 M94 M74 M-68 M-72 M108 M181 M287 M422 M446 M
TotalRevenue-6 M382000.0158333.031 M16 M169 M88 M138 M243 M241 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University